Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma: a multicenter study on 1383 patients of the prospective DeCOG registry ADOReg : cancer therapy and prevention

This study investigated whether adjuvant treatments in stage III cutaneous melanoma (CM) influenced patterns of recurrence. Patients with primary (n = 1033) or relapsed CM (n = 350) who received adjuvant therapies with Nivolumab (N), Pembrolizumab (P), or Dabrafenib and Trametinib (D + T) were extra...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Wohlfeil, Sebastian A. (VerfasserIn) , Kranzmann, Leonie (VerfasserIn) , Weiß, Christel (VerfasserIn) , von Wasielewski, Imke (VerfasserIn) , Klespe, Kai C. (VerfasserIn) , Kähler, Katharina C. (VerfasserIn) , Weichenthal, Michael (VerfasserIn) , Schadendorf, Dirk (VerfasserIn) , Zimmer, Lisa (VerfasserIn) , Mohr, Peter (VerfasserIn) , Meier, Friedegund (VerfasserIn) , Pfoehler, Claudia (VerfasserIn) , Berking, Carola (VerfasserIn) , Heppt, Markus V. (VerfasserIn) , Herbst, Rudolf (VerfasserIn) , Kreuter, Alexander (VerfasserIn) , Gutzmer, Ralf (VerfasserIn) , Ulrich, Jens (VerfasserIn) , Meiss, Frank (VerfasserIn) , Gebhardt, Christoffer (VerfasserIn) , Dippel, Edgar (VerfasserIn) , Leiter, Ulrike (VerfasserIn) , Schilling, Bastian (VerfasserIn) , Ugurel, Selma (VerfasserIn) , Utikal, Jochen (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 15 November 2024
In: International journal of cancer
Year: 2024, Jahrgang: 155, Heft: 10, Pages: 1808-1823
ISSN:1097-0215
DOI:10.1002/ijc.35078
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1002/ijc.35078
Verlag, kostenfrei, Volltext: http://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.35078
Volltext
Verfasserangaben:Sebastian A. Wohlfeil, Leonie Kranzmann, Christel Weiß, Imke von Wasielewski, Kai C. Klespe, Katharina C. Kähler, Michael Weichenthal, Dirk Schadendorf, Lisa Zimmer, Peter Mohr, Friedegund Meier, Claudia Pfoehler, Carola Berking, Markus V. Heppt, Rudolf Herbst, Alexander Kreuter, Ralf Gutzmer, Jens Ulrich, Frank Meiss, Christoffer Gebhardt, Edgar Dippel, Ulrike Leiter, Bastian Schilling, Selma Ugurel, Jochen Utikal

MARC

LEADER 00000caa a2200000 c 4500
001 1908954884
003 DE-627
005 20251111093839.0
007 cr uuu---uuuuu
008 241119s2024 xx |||||o 00| ||eng c
024 7 |a 10.1002/ijc.35078  |2 doi 
035 |a (DE-627)1908954884 
035 |a (DE-599)KXP1908954884 
035 |a (OCoLC)1475647515 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Wohlfeil, Sebastian A.  |e VerfasserIn  |0 (DE-588)1109821379  |0 (DE-627)864416334  |0 (DE-576)475626575  |4 aut 
245 1 0 |a Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma  |b a multicenter study on 1383 patients of the prospective DeCOG registry ADOReg : cancer therapy and prevention  |c Sebastian A. Wohlfeil, Leonie Kranzmann, Christel Weiß, Imke von Wasielewski, Kai C. Klespe, Katharina C. Kähler, Michael Weichenthal, Dirk Schadendorf, Lisa Zimmer, Peter Mohr, Friedegund Meier, Claudia Pfoehler, Carola Berking, Markus V. Heppt, Rudolf Herbst, Alexander Kreuter, Ralf Gutzmer, Jens Ulrich, Frank Meiss, Christoffer Gebhardt, Edgar Dippel, Ulrike Leiter, Bastian Schilling, Selma Ugurel, Jochen Utikal 
264 1 |c 15 November 2024 
300 |a 16 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Erstmals veröffentlicht: 08. Juli 2024 
500 |a Gesehen am 19.11.2024 
520 |a This study investigated whether adjuvant treatments in stage III cutaneous melanoma (CM) influenced patterns of recurrence. Patients with primary (n = 1033) or relapsed CM (n = 350) who received adjuvant therapies with Nivolumab (N), Pembrolizumab (P), or Dabrafenib and Trametinib (D + T) were extracted from the prospective multicenter real-world skin cancer registry ADOReg. Endpoints were progression-free survival (PFS), distant metastasis-free survival (DMFS), organ-specific DMFS, and overall survival (OS). For primary cases, D + T indicated an improved PFS (1- and 2-year PFS: 90.9%; 82.7%) as compared to P (81.0%, 73.9%; p = .0208), or N (83.8%, 75.2%; p = .0539). BRAF-mutated(mut) CM demonstrated significantly lower PFS (p = .0022) and decreased DMFS (p = .0580) when treated with immune checkpoint inhibitor (ICI) instead of D + T. Besides, NRAS-mut CM tended to perform worse than wt CM upon ICI (PFS: p = .1349; DMFS: p = .0540). OS was similar between the groups. Relapsed cases showed decreased PFS, DMFS, and OS in comparison to primary (all: p < .001), without significant differences between the subgroups. Organ-specific DMFS was significantly altered for primary cases with bone (p = .0367) or brain metastases (p = .0202). In relapsed CM, the frequency of liver (D + T: 1.5%; P: 12%; N: 9%) and LN metastases (D + T: 1.5%; P: 12%; N: 10.2%) was significantly lower with adjuvant D + T than ICI. NRAS-mut CM showed increased recurrence in primary and relapsed cases. These data show that adjuvant D + T is superior to ICI in primary BRAF-mut CM. 
650 4 |a adjuvant treatment 
650 4 |a immune checkpoint inhibition 
650 4 |a melanoma 
650 4 |a targeted therapy 
650 4 |a therapy resistance 
700 1 |a Kranzmann, Leonie  |d 1999-  |e VerfasserIn  |0 (DE-588)1348713143  |0 (DE-627)1908955139  |4 aut 
700 1 |a Weiß, Christel  |d 1958-  |e VerfasserIn  |0 (DE-588)123287707  |0 (DE-627)082463417  |0 (DE-576)168356104  |4 aut 
700 1 |a von Wasielewski, Imke  |e VerfasserIn  |4 aut 
700 1 |a Klespe, Kai C.  |e VerfasserIn  |4 aut 
700 1 |a Kähler, Katharina C.  |e VerfasserIn  |4 aut 
700 1 |a Weichenthal, Michael  |e VerfasserIn  |0 (DE-588)140953272  |0 (DE-627)623003848  |0 (DE-576)321514157  |4 aut 
700 1 |a Schadendorf, Dirk  |d 1960-  |e VerfasserIn  |0 (DE-588)11142576X  |0 (DE-627)499566076  |0 (DE-576)289702275  |4 aut 
700 1 |a Zimmer, Lisa  |e VerfasserIn  |4 aut 
700 1 |a Mohr, Peter  |e VerfasserIn  |4 aut 
700 1 |a Meier, Friedegund  |e VerfasserIn  |4 aut 
700 1 |a Pfoehler, Claudia  |e VerfasserIn  |4 aut 
700 1 |a Berking, Carola  |e VerfasserIn  |4 aut 
700 1 |a Heppt, Markus V.  |d 1987-  |e VerfasserIn  |0 (DE-588)1072242346  |0 (DE-627)827081111  |0 (DE-576)43371767X  |4 aut 
700 1 |a Herbst, Rudolf  |e VerfasserIn  |4 aut 
700 1 |a Kreuter, Alexander  |d 1971-  |e VerfasserIn  |0 (DE-588)132383993  |0 (DE-627)521950546  |0 (DE-576)299112063  |4 aut 
700 1 |a Gutzmer, Ralf  |d 1968-  |e VerfasserIn  |0 (DE-588)113713371  |0 (DE-627)502213558  |0 (DE-576)289772095  |4 aut 
700 1 |a Ulrich, Jens  |e VerfasserIn  |4 aut 
700 1 |a Meiss, Frank  |e VerfasserIn  |4 aut 
700 1 |a Gebhardt, Christoffer  |e VerfasserIn  |4 aut 
700 1 |a Dippel, Edgar  |e VerfasserIn  |4 aut 
700 1 |a Leiter, Ulrike  |e VerfasserIn  |4 aut 
700 1 |a Schilling, Bastian  |e VerfasserIn  |4 aut 
700 1 |a Ugurel, Selma  |d 1971-  |e VerfasserIn  |0 (DE-588)122030923  |0 (DE-627)081693532  |0 (DE-576)293057567  |4 aut 
700 1 |a Utikal, Jochen  |d 1974-  |e VerfasserIn  |0 (DE-588)1026463750  |0 (DE-627)726765015  |0 (DE-576)371816580  |4 aut 
773 0 8 |i Enthalten in  |t International journal of cancer  |d Bognor Regis : Wiley-Liss, 1966  |g 155(2024), 10 vom: Nov., Seite 1808-1823  |h Online-Ressource  |w (DE-627)269532781  |w (DE-600)1474822-8  |w (DE-576)079876129  |x 1097-0215  |7 nnas  |a Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma a multicenter study on 1383 patients of the prospective DeCOG registry ADOReg : cancer therapy and prevention 
773 1 8 |g volume:155  |g year:2024  |g number:10  |g month:11  |g pages:1808-1823  |g extent:16  |a Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma a multicenter study on 1383 patients of the prospective DeCOG registry ADOReg : cancer therapy and prevention 
856 4 0 |u https://doi.org/10.1002/ijc.35078  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u http://onlinelibrary.wiley.com/doi/abs/10.1002/ijc.35078  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20241119 
993 |a Article 
994 |a 2024 
998 |g 1026463750  |a Utikal, Jochen  |m 1026463750:Utikal, Jochen  |d 60000  |e 60000PU1026463750  |k 0/60000/  |p 25  |y j 
998 |g 122030923  |a Ugurel, Selma  |m 122030923:Ugurel, Selma  |d 60000  |e 60000PU122030923  |k 0/60000/  |p 24 
998 |g 11142576X  |a Schadendorf, Dirk  |m 11142576X:Schadendorf, Dirk  |d 50000  |e 50000PS11142576X  |k 0/50000/  |p 8 
998 |g 123287707  |a Weiß, Christel  |m 123287707:Weiß, Christel  |d 60000  |d 60200  |d 60250  |d 60000  |e 60000PW123287707  |e 60200PW123287707  |e 60250PW123287707  |e 60000PW123287707  |k 0/60000/  |k 1/60000/60200/  |k 2/60000/60200/60250/  |k 0/60000/  |p 3 
998 |g 1348713143  |a Kranzmann, Leonie  |m 1348713143:Kranzmann, Leonie  |d 60000  |e 60000PK1348713143  |k 0/60000/  |p 2 
998 |g 1109821379  |a Wohlfeil, Sebastian A.  |m 1109821379:Wohlfeil, Sebastian A.  |d 60000  |d 61900  |e 60000PW1109821379  |e 61900PW1109821379  |k 0/60000/  |k 1/60000/61900/  |p 1  |x j 
999 |a KXP-PPN1908954884  |e 4616306176 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"corporate":[{"role":"isb","display":"International Union against Cancer"}],"id":{"eki":["269532781"],"zdb":["1474822-8"],"doi":["10.1002/(ISSN)1097-0215"],"issn":["1097-0215"]},"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"dateIssuedKey":"1966","publisher":"Wiley-Liss","dateIssuedDisp":"1966-","publisherPlace":"Bognor Regis"}],"title":[{"title":"International journal of cancer","subtitle":"publication of the International Union against Cancer (UICC) = Journal international du cancer","title_sort":"International journal of cancer"}],"note":["Gesehen am 28.02.08","Darin: Predictive oncology"],"language":["eng"],"recId":"269532781","pubHistory":["1.1966 -"],"titleTranslated":[{"translated":"Journal international du cancer"}],"part":{"text":"155(2024), 10 vom: Nov., Seite 1808-1823","issue":"10","volume":"155","extent":"16","pages":"1808-1823","year":"2024"},"titleAlt":[{"title":"Predictive oncology"}],"disp":"Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma a multicenter study on 1383 patients of the prospective DeCOG registry ADOReg : cancer therapy and preventionInternational journal of cancer"}],"recId":"1908954884","title":[{"subtitle":"a multicenter study on 1383 patients of the prospective DeCOG registry ADOReg : cancer therapy and prevention","title_sort":"Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma","title":"Influence of adjuvant therapies on organ-specific recurrence of cutaneous melanoma"}],"note":["Erstmals veröffentlicht: 08. Juli 2024","Gesehen am 19.11.2024"],"language":["eng"],"person":[{"display":"Wohlfeil, Sebastian A.","family":"Wohlfeil","role":"aut","given":"Sebastian A."},{"family":"Kranzmann","display":"Kranzmann, Leonie","given":"Leonie","role":"aut"},{"family":"Weiß","display":"Weiß, Christel","given":"Christel","role":"aut"},{"given":"Imke","role":"aut","family":"von Wasielewski","display":"von Wasielewski, Imke"},{"role":"aut","given":"Kai C.","display":"Klespe, Kai C.","family":"Klespe"},{"family":"Kähler","display":"Kähler, Katharina C.","given":"Katharina C.","role":"aut"},{"display":"Weichenthal, Michael","family":"Weichenthal","role":"aut","given":"Michael"},{"role":"aut","given":"Dirk","display":"Schadendorf, Dirk","family":"Schadendorf"},{"role":"aut","given":"Lisa","display":"Zimmer, Lisa","family":"Zimmer"},{"given":"Peter","role":"aut","family":"Mohr","display":"Mohr, Peter"},{"display":"Meier, Friedegund","family":"Meier","role":"aut","given":"Friedegund"},{"display":"Pfoehler, Claudia","family":"Pfoehler","role":"aut","given":"Claudia"},{"given":"Carola","role":"aut","family":"Berking","display":"Berking, Carola"},{"family":"Heppt","display":"Heppt, Markus V.","given":"Markus V.","role":"aut"},{"role":"aut","given":"Rudolf","display":"Herbst, Rudolf","family":"Herbst"},{"given":"Alexander","role":"aut","family":"Kreuter","display":"Kreuter, Alexander"},{"role":"aut","given":"Ralf","display":"Gutzmer, Ralf","family":"Gutzmer"},{"display":"Ulrich, Jens","family":"Ulrich","role":"aut","given":"Jens"},{"given":"Frank","role":"aut","family":"Meiss","display":"Meiss, Frank"},{"given":"Christoffer","role":"aut","family":"Gebhardt","display":"Gebhardt, Christoffer"},{"family":"Dippel","display":"Dippel, Edgar","given":"Edgar","role":"aut"},{"family":"Leiter","display":"Leiter, Ulrike","given":"Ulrike","role":"aut"},{"given":"Bastian","role":"aut","family":"Schilling","display":"Schilling, Bastian"},{"role":"aut","given":"Selma","display":"Ugurel, Selma","family":"Ugurel"},{"display":"Utikal, Jochen","family":"Utikal","role":"aut","given":"Jochen"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"16 S."}],"id":{"doi":["10.1002/ijc.35078"],"eki":["1908954884"]},"name":{"displayForm":["Sebastian A. Wohlfeil, Leonie Kranzmann, Christel Weiß, Imke von Wasielewski, Kai C. Klespe, Katharina C. Kähler, Michael Weichenthal, Dirk Schadendorf, Lisa Zimmer, Peter Mohr, Friedegund Meier, Claudia Pfoehler, Carola Berking, Markus V. Heppt, Rudolf Herbst, Alexander Kreuter, Ralf Gutzmer, Jens Ulrich, Frank Meiss, Christoffer Gebhardt, Edgar Dippel, Ulrike Leiter, Bastian Schilling, Selma Ugurel, Jochen Utikal"]},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"15 November 2024"}]} 
SRT |a WOHLFEILSEINFLUENCEO1520